Mouth ulcer treatment with rebamipide vs. steroid cream
Part of Infections, Mouth & dental clinical trials.
This study compares two mouth ulcer treatments: a newer medication called rebamipide and a standard steroid cream. It aims to see which one heals mouth ulcers faster and better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You currently have an active mouth ulcer (canker sore).
- You have had mouth ulcers before (they keep coming back).
- You have no other visible mouth sores or conditions besides the aphthous ulcers.
- You are willing to participate and use the study treatments.
- You do not have serious medical conditions like heart failure, cancer, tuberculosis, hepatitis, or HIV.
- You are not taking immunosuppressive drugs or any other mouth ulcer treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether applying a strong steroid cream (betamethasone) with the help of ultrasound waves (phonophoresis) can repigment vitiligo patches. It aims to see if this combination works better than the cream alone.
This trial tests whether a pineapple enzyme (bromelain) works as well as a standard steroid treatment for painful mouth sores caused by oral lichen planus. If you have this condition and are not taking other medications, you may be eligible.
This study compares two treatments for recurrent mouth ulcers (aphthous stomatitis): a topical enzyme called bromelain and a topical corticosteroid. The goal is to see which is more effective at healing the ulcers and reducing pain.
This study tests whether a steroid mouthwash and/or light therapy (photobiomodulation) can help heal painful mouth sores caused by pemphigus vulgaris, an autoimmune disease that damages the inside of the mouth and skin.
This Phase 3 trial tests whether apremilast can reduce severe, recurring mouth ulcers compared with an inactive placebo. It aims to improve ulcer frequency and pain while carefully checking safety.
This trial studies lenalidomide to treat frequent, ongoing mouth ulcers caused by mucosal Behçet’s syndrome. It’s meant for people whose mouth sores keep coming back despite standard treatments like steroid medicines and other immune-suppressing drugs.
Hear when a new Oral Aphthous Ulcers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.